Blueberries: A Triple Threat Against Triple-Negative Breast Cancers

City of Hope researchers and study authors Shiuan Chen, Ph.D., and Lynn Adams, Ph.D. discuss the results of a recent research study on the effects of blueberries on breast cancer. Chen, research f... Author: feeds Added: 08/30/2013
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts

Related Links:

ConclusionsPractical difficulties in quantifying quality of life losses and healthcare expenditures owing to competing risks in life years gained can be overcome. Their inclusion can have a substantial impact on the cost-effectiveness of cancer screening programs.
Source: American Journal of Preventive Medicine - Category: International Medicine & Public Health Source Type: research
Authors: Colhado Rodrigues BL, Lallo MA, Perez EC Abstract Autophagy is a natural regulatory mechanism of the cell that eliminates unnecessary and dysfunctional cellular components to maintain homeostasis. Several authors have demonstrated that this mechanism can be induced by pathological conditions as cancer. However, their role in tumor development is still a controversial issue in cancer research. Here, we discussed the most relevant findings concerning autophagy in tumor development. In this critical review performed with studies published between 2002 and 2018, we found that the main pathway involved in the a...
Source: Immunological Investigations - Category: Allergy & Immunology Tags: Immunol Invest Source Type: research
ConclusionKi67 is correlated with the grade of the tumor, and is not a predictor for the survival of breast cancer patients. It may predict aggressive behavior of the tumor and higher histopathological grades.
Source: Annals of Medicine and Surgery - Category: General Medicine Source Type: research
AbstractPurposeTumor inflammatory response was evaluated as a prognostic feature in triple-negative breast cancer (TNBC) and compared with the clinical prognosticators of breast cancer and selected biomarkers of cancer cell proliferation.MethodsTNBC patients (n = 179) with complete clinical data and up to 18-year follow-up were obtained from Auria biobank, Turku University Hospital, Turku, Finland. Tumor-infiltrating lymphocytes (TILs) and several subtypes of inflammatory cells detected with immunohistochemistry were evaluated in different tumor compa rtments in full tissue sections and tissue microarrays.Res...
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research
Women with schizophrenia are only half as likely as women in the general population to receive mammograms, reports ameta-analysis published inPsychiatric Services in Advance.“Lower screening rates could explain why women with schizophrenia and other serious mental illnesses are found to have more advanced breast cancer at time of diagnosis,” wrote Alison Hwong, M.D., Ph.D., and colleagues at the University of California, San Francisco. “Given the high prevalence o f breast cancer and the promising prognosis of breast cancer if detected early, mammography screening is a key first step in improving diagnosi...
Source: Psychiatr News - Category: Psychiatry Tags: Alison Hwong breast cancer cancer screening mammogram meta-analysis preventive service Psychiatric Services in Advance psychotic disorders schizophrenia Source Type: research
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, Alternative Medicine, News, Source Type: news
Conditions:   Breast Cancer;   Breast Cancer Lymphedema;   Pain;   Pain, Postoperative;   Pain, Chronic;   Mastectomy; Lymphedema;   Breast Surgery Interventions:   Other: Single rehabilitative treatment;   Other: Group rehabilitative treatment Sponsor:   University of Roma La Sapienza Completed
Source: - Category: Research Source Type: clinical trials
Condition:   Breast Cancer Intervention:   Drug: Vitamin D Sponsor:   Damanhour University Not yet recruiting
Source: - Category: Research Source Type: clinical trials
Condition:   Metastatic Breast Cancer Interventions:   Drug: KN026 combination;   Drug: KN026 monotherapy Sponsor:   Jiangsu Alphamab Biopharmaceuticals Co., Ltd Not yet recruiting
Source: - Category: Research Source Type: clinical trials
Conditions:   Lymphedema of Upper Limb;   Breast Cancer Related Lymphedema Intervention:   Combination Product: bupivacaine and triamcinolone Sponsor:   Marmara University Enrolling by invitation
Source: - Category: Research Source Type: clinical trials
More News: Blueberries | Breast Cancer | Cancer | Cancer & Oncology | Study